Epalrestat
Catalog No.
B1743
aldose reductase inhibitor
Featured Products
Epalrestat
- 1. Dmitri R. Davydov, Kannapiran Ponraj, et al. "A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11." Biochem J. 2025 Jun 17;482(12):839–857 PMID: 40454940
- 2. Huafang Jia, Mengru Liu, et al. "Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway." J Neuroinflammation. 2025 Apr 29;22(1):125 PMID: 40301912
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 319.4 |
| Cas No. | 82159-09-9 |
| Formula | C15H13NO3S2 |
| Solubility | insoluble in H2O; insoluble in EtOH; ≥6.375 mg/mL in DMSO with gentle warming |
| Chemical Name | 2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid |
| SDF | Download SDF |
| Canonical SMILES | CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
